United States · FDA National Drug Code directory
Anastrozole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-2791_31e27616-7902-a78b-e063-6394a90a5f5a
- Product NDC
- 68071-2791
- Form
- TABLET
- Composition / generic term
- Anastrozole
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100622
- Source listing expiry
- 20261231
Source-listed ingredients
- ANASTROZOLE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 8 TABLET in 1 BOTTLE, PLASTIC (68071-2791-0) · 68071-2791-0
- 20 TABLET in 1 BOTTLE, PLASTIC (68071-2791-2) · 68071-2791-2
- 15 TABLET in 1 BOTTLE, PLASTIC (68071-2791-5) · 68071-2791-5
- 12 TABLET in 1 BOTTLE, PLASTIC (68071-2791-7) · 68071-2791-7
- 180 TABLET in 1 BOTTLE, PLASTIC (68071-2791-8) · 68071-2791-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →